Hyperprolactinemia contributes to mood and sleep disturbances.

Hyperprolactinemia significantly influences mood and sleep through both direct central nervous system signaling and indirect suppression of reproductive hormones. Prolactin acts as a potent neurohormone that crosses the blood-brain barrier, interacting with specific receptors in brain regions responsible for emotional regulation and sleep architecture.

Clinical and effectiveness evidence

Clinical observations consistently link elevated prolactin levels with psychological distress and altered sleep patterns.

• Mood Disturbances: Patients with hyperprolactinemia, such as those with prolactinomas, frequently report higher rates of anxiety, depression, hostility, and somatization. These symptoms often show significant improvement following treatment with dopamine agonists or surgical intervention.
• Sleep Architecture: Prolactin levels naturally peak during sleep, specifically during non-REM (NREM) cycles. Pathological elevations are associated with disruptions in sleep-wake regulation, including excessive daytime sleepiness and changes in REM sleep frequency. Research indicates that prolactin elevation is correlated with increased EEG delta activity, which is a marker of deep NREM sleep.

Mechanistic explanations

The impact of hyperprolactinemia is mediated through two primary biological pathways:

• Central Signaling: Prolactin enters the brain via receptor-mediated transport at the choroid plexus. Once central, it binds to receptors in the hypothalamus, hippocampus, and amygdala. It modulates mood by activating signaling pathways such as JAK2/STAT5 and MAPK/ERK, which influence hippocampal neurogenesis and the transcription of corticotropin-releasing hormone (CRH).
• Reproductive Hormone Suppression: High prolactin levels inhibit the pulsatile release of gonadotropin-releasing hormone (GnRH). This leads to a cascade that reduces luteinizing hormone (LH) and follicle-stimulating hormone (FSH), resulting in low estrogen and progesterone levels. This hypoestrogenic state is a known contributor to mood lability and sleep fragmentation, as estrogen plays a critical role in serotonin synthesis and the maintenance of core body temperature regulation during sleep.

Clinical implications

For women in their 40s, hyperprolactinemia can exacerbate or mimic perimenopausal symptoms due to this secondary hypogonadism.

• Hormonal Crosstalk: The suppression of the hypothalamic-pituitary-gonadal (HPG) axis by prolactin creates a hormonal environment similar to menopause, which independently increases the risk for insomnia and depressive symptoms.
• Diagnostic Consideration: When patients present with concurrent mood changes and sleep disturbances, evaluating prolactin levels is essential, as these symptoms may be direct neurological consequences of the hormone or secondary effects of reproductive hormone depletion.

Bottom line

Hyperprolactinemia contributes to mood and sleep disturbances through a dual mechanism: direct neuroendocrine signaling in the brain and the secondary suppression of estrogen and progesterone. Addressing the underlying cause of elevated prolactin is often effective in resolving these neuropsychiatric and somatic symptoms.